Article Figures & Data
Figures
- Figure 1.
Overall survival in patients with and without sarcopenia with unresectable locally advanced esophageal cancer treated with definitive chemoradiotherapy. The difference in overall survival between the sarcopenia group (n=34) and the non-sarcopenia group (n=14) was significant (36.95% vs. 63.9%, p=0.018).
Tables
In this issue
Jump to section
Related Articles
Cited By...
- Prognostic Value of Radiomics Analysis of Skeletal Muscle After Radical Irradiation of Esophageal Cancer
- Association Between Sarcopenia and Clinical Outcomes in Patients With Esophageal Cancer Under Neoadjuvant Therapy
- Lymphopenia in Esophageal Squamous Cell Carcinoma: Relationship to Malnutrition, Various Disease Parameters, and Response to Concurrent Chemoradiotherapy
- Foamy Histiocyte-like Esophageal Adenocarcinoma: Unusual Morphology and Diagnostic Pitfalls